Updates on Pityriasis Rubra Pilaris: A Scoping Review
Journal of Cutaneous Medicine and Surgery · 2024
DOI: 10.1177/12034754231223159 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Cutaneous Medicine and Surgery, 2024. Verfasst von Ted Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada. Hauptthemen laut MEDLINE: Pityriasis Rubra Pilaris, Psoriasis, COVID-19. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Pityriasis rubra pilaris (PRP) is a rare, inflammatory papulosquamous skin disease with unknown exact etiology. Historically, PRP has been challenging to diagnose, especially during the acute phase, and to treat, due to its unclear pathogenesis. To better inform clinical practice, a literature review was conducted employing a broad search strategy to capture PRP-related published studies between January 1, 2012 to October 31, 2022. Two hundred twenty-one studies were identified, which were categorized into 9 themes: (1) potential causes and triggering factors, (2) comorbidities, (3) diagnostic difficulties, (4) genetics, (5) clinical manifestations and laboratory values, (6) treatment, (7) treatment-related adverse events, (8) quality of life, and (9) other. COVID-19 infection, COVID-19 vaccination, and malignancy were the most commonly reported potential triggering factors. Misdiagnosis is very common during the early acute stages. Pathogenesis and genetic studies have further implicated caspase recruitment domain family member 14 (CARD14) mutations in the development of familial PRP (Type V) and have underlined the overlap between psoriasis and PRP. To date, there are currently no specific and validated scoring systems or tools to assess the severity of PRP. While large, randomized trials are still lacking, biologic agents remain the most effective therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
- Division of Dermatology, Department of Medicine, McMaster University, Hamilton, ON, Canada.
ORCID-Profile: Ted Zhou, Mohannad Abu-Hilal
Zitieren
APA
Zhou, T., Al Muqrin, A., & Abu-Hilal, M. (2024). Updates on Pityriasis Rubra Pilaris: A Scoping Review. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754231223159
Vancouver
Zhou T, Al Muqrin A, Abu-Hilal M. Updates on Pityriasis Rubra Pilaris: A Scoping Review. Journal of Cutaneous Medicine and Surgery. 2024. doi:10.1177/12034754231223159
BibTeX
@article{Zhou2024,
author = {Zhou, Ted and Al Muqrin, Abdullah and Abu-Hilal, Mohannad},
title = {Updates on Pityriasis Rubra Pilaris: A Scoping Review},
journal = {Journal of Cutaneous Medicine and Surgery},
year = {2024},
doi = {10.1177/12034754231223159}
}
EUVIMED